1Perry EK, Picketing AT, Wang WW, et al. Medicinal plants and Alzheimer' s disease: from ethnobotany to phytotherapy[ J ]. J Pharm Pharmacol, 1999, 51: 527-534.
2Parnetti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease. The way forward[ J ] .Drugs, 1997, 53 ( 5 ): 752-768.
3Lin J, Zhang HY, Wang LM, et al. Inhibitory effects of huperzine B on cholinesterase activity in mice[ J ] .Acta Pharmacol Sin, 1999, 20 ( 2 ): 141-145.
4Park CH, Kim SH, Choi W, et al. Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutacearpa[ J ] .Planta Med, 1996, 62 ( 5 ): 405-409.
5Hardy JA, Higgins GA. Alzheimer' s disease: the amyioid cascade hypothesis[ J ] .Science, 1992, 256: 184.
6Choiw. Protective effects of bilobalide on amiloid beta-peptide 25-35-induced PC12 cell cytotoxicity[ J ] .Acta Phamacol Sin, 2000 ( 1 ): 75.
7Zhou LJ, Zhu-XZ. Reactive oxygen species-induced apeptosis in PC12 cells and protective effect of bilobalide[ J ]. J Pharmacol Exp Ther, 2000,293 ( 3 ): 982-988.
8Markesbery WR. Oxidative stress hypothesis in Alzheimer' s disease[ J ] .Free Radic Biol Med, 1997, 23: 134-147.
9Harman D. The aging process[ J ] .Proe Natl Acad Sci USA, 1981, 78: 7124-7128.
10Tang XC. Huperzine A(Shuangyiping): a promising drug for Alzheimer' s disease[ J ] .Aeta Pharmacol Sin, 1996, 17: 481-484.
